|
Aisling Capital |
|
United States |
+1 (212) 651-6380 |
Series A |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
+1 (626) 578-0777 |
Seed |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
6265780777 |
Seed |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
(626) 578-0777 |
Seed |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
+1 (626) 578-0777 |
Series A |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
6265780777 |
Series A |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
(626) 578-0777 |
Series A |
|
|
|
Brian Dixon |
Individual investor. |
|
|
N/A |
|
|
|
CHL Medical Partners |
Venture capital firm focused on early-stage healthcare sectors. |
United States |
+1 (203) 324-7700 |
Seed |
|
|
|
CHL Medical Partners |
Venture capital firm focused on early-stage healthcare sectors. |
United States |
+1 (203) 324-7700 |
Series A |
|
|
|
Connecticut Innovations Inc (CI) |
|
United States |
+1 (860) 563-5851 |
N/A |
|
|
|
Elm Street Ventures |
|
United States |
+1 (203) 401-4201 |
Series A |
|
|
|
Elm Street Ventures |
|
United States |
+1 (203) 401-4201 |
Seed |
|
|
|
New Leaf Venture Partners (NLV) |
|
United States |
+1 (646) 871-6400 |
Series A |
|
|
|
New Leaf Venture Partners (NLV) |
|
United States |
+1 (646) 871-6400 |
N/A |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series A |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Seed |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
N/A |
|
|
|
OpGen Inc |
Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. |
United States |
|
N/A |
|
|